FDA Seeks Input on Generative AI Medical Device Regulation
The agency released a discussion paper to address the unique risks and potential of generative artificial intelligence in the healthcare ecosystem.
The agency released a discussion paper to address the unique risks and potential of generative artificial intelligence in the healthcare ecosystem.
New collaborations with six technology companies integrate wearable and out-of-hospital tools to improve patient visibility and care coordination.
Imaging equipment is becoming more complex, and experienced imaging engineers are harder to find. Industry leaders discuss how HTM teams can respond.
The agency released a discussion paper to address the unique risks and potential of generative artificial intelligence in the healthcare ecosystem.
A side-by-side look at defibrillator analyzers, comparing key performance specs, features, and pricing.
The technology, based on research from Stanford University, will be integrated into Leo Cancer Care platforms with the first installation at Mayo Clinic.
The Food and Drug Administration classifies the recall as the most serious type after reports of touchscreen malfunctions caused by dropped or jarred devices.
From preserving institutional knowledge to accelerating technician development, AI could become one of HTM's most valuable workforce tools.
The program offers mail-in calibration, scheduled reminders, and shipment tracking to help facilities maintain accurate survey meter performance and meet regulatory requirements.
The five-year project funded by ARPA-H aims to develop ultra-high dose rate photon therapy for standard linear accelerators.
The medical-grade ice-based container replaces traditional cardboard and Styrofoam packaging to improve safety and reliability during organ shipping.
The expanded partnership brings integrated patient monitoring technologies into outpatient settings as more procedures shift away from hospitals.
Analysis of 21 models shows gaps in early-stage decision-making, reinforcing need for clinician oversight as AI tools enter care settings.
The acquisition includes exclusive rights to the FDA-cleared xvision Spine System, which uses augmented reality for surgical navigation.